The Efficacy and Safety of a Novel PD-1/CTLA-4 Bispecific Antibody Cadonilimab (AK104) in Advanced Non-Small Cell Lung Cancer: A Multicenter Retrospective Observational Study in China.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined